Recent Financing
Recent Raise
Slate Medicines is a biotechnology company developing next-generation monoclonal and bispecific antibodies for migraine, including PACAP/VIP-targeting and CGRP+PACAP/VIP candidates.
Focus Areas
Recent Investors
Total Raised
Funding rounds
See the team members at Slate Medicines.
